|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
61,398,000 |
Market
Cap: |
304.53(M) |
Last
Volume: |
907,467 |
Avg
Vol: |
710,310 |
52
Week Range: |
$3.38 - $6.5 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Vanda Pharmaceuticals is a biopharmaceutical company. Co.'s commercial portfolio is comprised of two products, HETLIOZ® for the treatment of Non-24 Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome and Fanapt® for the treatment of schizophrenia. In addition, Co. has a number of drugs in development, including: Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist, for the treatment of gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia; and VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for several oncology indications.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
2,251 |
2,251 |
123,349 |
363,323 |
Total Sell Value |
$13,327 |
$13,327 |
$526,672 |
$2,473,859 |
Total People Sold |
1 |
1 |
5 |
6 |
Total Sell Transactions |
1 |
1 |
11 |
29 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Williams Timothy |
SVP & General Counsel |
|
2021-03-02 |
4 |
S |
$18.54 |
$142,307 |
D/D |
(7,674) |
92,526 |
|
- |
|
Birznieks Gunther |
SVP, Business Development |
|
2021-03-02 |
4 |
S |
$18.19 |
$302,273 |
D/D |
(16,620) |
171,708 |
|
- |
|
Moran Kevin Patrick |
SVP, CFO & Treasurer |
|
2021-03-02 |
4 |
S |
$18.23 |
$110,191 |
D/D |
(6,044) |
101,426 |
|
- |
|
Polymeropoulos Mihael Hristos |
President and CEO |
|
2021-03-01 |
4 |
S |
$18.45 |
$138,003 |
D/D |
(7,479) |
1,411,268 |
|
- |
|
Williams Timothy |
SVP & General Counsel |
|
2021-03-01 |
4 |
S |
$18.60 |
$220,543 |
D/D |
(11,856) |
100,200 |
|
- |
|
Birznieks Gunther |
SVP, Business Development |
|
2021-03-01 |
4 |
S |
$18.66 |
$71,744 |
D/D |
(3,845) |
188,328 |
|
- |
|
Moran Kevin Patrick |
SVP, CFO & Treasurer |
|
2021-03-01 |
4 |
S |
$18.57 |
$61,780 |
D/D |
(3,327) |
107,470 |
|
- |
|
Williams Timothy |
SVP & General Counsel |
|
2021-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
32,700 |
112,056 |
|
- |
|
Birznieks Gunther |
SVP, Business Development |
|
2021-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
32,700 |
192,173 |
|
- |
|
Polymeropoulos Mihael Hristos |
President and CEO |
|
2021-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
115,000 |
1,418,747 |
|
- |
|
Wijkstrom Joakim |
SVP, Chief Marketing Officer |
|
2021-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
25,800 |
82,090 |
|
- |
|
Jones Aranthan Ii |
Chief Corp. Affairs Officer |
|
2021-02-24 |
4 |
S |
$20.01 |
$460,033 |
D/D |
(22,986) |
100,800 |
|
- |
|
Jones Aranthan Ii |
Chief Corp. Affairs Officer |
|
2021-02-24 |
4 |
OE |
$12.27 |
$276,063 |
D/D |
22,499 |
123,786 |
|
- |
|
Jones Aranthan Ii |
Chief Corp. Affairs Officer |
|
2021-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
25,800 |
101,287 |
|
- |
|
Moran Kevin Patrick |
SVP, CFO & Treasurer |
|
2021-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
32,700 |
110,797 |
|
- |
|
Dugan Richard W |
Director |
|
2021-02-16 |
4 |
S |
$18.54 |
$106,663 |
D/D |
(5,754) |
54,887 |
|
- |
|
Dugan Richard W |
Director |
|
2021-02-16 |
4 |
OE |
$7.11 |
$106,650 |
D/D |
15,000 |
60,641 |
|
- |
|
Watkins Thomas |
Director |
|
2021-02-16 |
4 |
S |
$18.54 |
$107,856 |
D/D |
(5,818) |
49,505 |
|
- |
|
Watkins Thomas |
Director |
|
2021-02-16 |
4 |
OE |
$7.11 |
$106,650 |
D/D |
15,000 |
55,323 |
|
- |
|
Polymeropoulos Mihael Hristos |
President and CEO |
|
2020-12-15 |
4 |
S |
$13.00 |
$508,844 |
D/D |
(39,150) |
1,303,747 |
|
- |
|
Polymeropoulos Mihael Hristos |
President and CEO |
|
2020-12-15 |
4 |
OE |
$8.75 |
$408,301 |
D/D |
46,663 |
1,342,897 |
|
- |
|
Polymeropoulos Mihael Hristos |
President and CEO |
|
2020-12-14 |
4 |
S |
$13.19 |
$673,306 |
D/D |
(51,049) |
1,296,234 |
|
- |
|
Polymeropoulos Mihael Hristos |
President and CEO |
|
2020-12-14 |
4 |
OE |
$8.75 |
$538,300 |
D/D |
61,520 |
1,347,283 |
|
- |
|
Polymeropoulos Mihael Hristos |
President and CEO |
|
2020-12-11 |
4 |
S |
$12.88 |
$451,360 |
D/D |
(35,053) |
1,285,763 |
|
- |
|
Polymeropoulos Mihael Hristos |
President and CEO |
|
2020-12-11 |
4 |
OE |
$8.75 |
$365,899 |
D/D |
41,817 |
1,320,816 |
|
- |
|
277 Records found
|
|
Page 5 of 12 |
|
|